Comment Letters

  •   Dear Dr. Lawrence: The Medical Imaging & Technology Alliance (MITA) is pleased to submit comments on the Agency for Healthcare Research and Quality (AHRQ) draft comparative effectiveness report entitled Radiotherapy Treatments for Head and Neck Cancer (“Draft Report”). MITA has extensive knowledge of the substantial benefits afforded by radiation therapy and medical imaging to Read More

  •   Dear Ms. Hake: The Medical Imaging and Technology Alliance (MITA) is pleased to submit comments on the Centers for Medicare and Medicaid Services’ (CMS) preliminary HCPCS decisions, published on April 23, 2014 (the “preliminary decisions”). As the leading trade association representing medical imaging, radiotherapy, and radiopharmaceutical manufacturers, we have in-depth knowledge of the significant Read More

  • Dear Director Teeter: The Medical Imaging and Technology Alliance (MITA) is pleased to submit comments on the Washington State Health Care Authority (HCA) Health Technology Assessment (HTA) Topic Selection 2014 (“Topic Selection”). As the leading trade association representing medical imaging, radiotherapy, and radiopharmaceutical manufacturers, we have in-depth knowledge of the significant benefits to the health Read More

  • Dear Dr. Hamburg: The Medical Imaging and Technology Alliance (MITA) is pleased to submit comments on the Food and Drug Administration’s (FDA) request for comments on its draft guidance regarding the recommended practices for the distribution of scientific and medical publications on unapproved new uses, as published in the Federal Register on March 3, 2014. Read More

  • RE: Ultrasound for Diagnostic Evaluation of Goiter Suspected or Detected on Physical Examination Dear Director Teeter: The Medical Imaging and Technology Alliance (MITA) is pleased to submit comments on the Washington State Health Care Authority Draft Key Questions on Ultrasound for Diagnostic Evaluation of Goiter Suspected or Detected on Physical Examination (“Draft Key Questions”). As Read More

  • Dear Dr. Shuren: The Medical Imaging and Technology Alliance (MITA) is pleased to submit comments on the Food and Drug Administration’s (FDA) request for comments on its draft guidance regarding the reporting of computational modeling studies in medical device submissions, as published in the Federal Register on January 17, 2014. MITA is the collective voice Read More

  •   RE:  National Coverage Analysis (NCA) Tracking Sheet for Lung Cancer Screening with Low Dose Computed Tomography (CAG-00439N) Dear Ms. Jensen: The Medical Imaging and Technology Alliance (MITA) is pleased to submit comments on the Centers for Medicare and Medicaid Services’ (CMS) national coverage analysis (NCA) tracking sheet on lung cancer screening with low dose Read More

  • Dear Dr. Berliner: The Medical Imaging & Technology Alliance (MITA) is pleased to submit comments on the Agency for Healthcare Research and Quality (AHRQ) draft technical brief entitled Imaging Techniques for Treatment Evaluation for Metastatic Breast Cancer (“Draft Technical Brief”). MITA has extensive knowledge of the substantial benefits afforded by medical imaging and radiation therapy Read More

  • RE: AHRQ Draft Key Questions on Non-Invasive Testing for Coronary Artery Disease Dear Dr. Kronick: The Medical Imaging & Technology Alliance (MITA) is pleased to submit comments on the Agency for Healthcare Research and Quality (AHRQ) draft key questions entitled Non-Invasive Testing for Coronary Artery Disease (“Draft Key Questions”). MITA has extensive knowledge of the Read More

  • Dear Chairwoman Moyer: The Medical Imaging and Technology Alliance (MITA) is pleased to submit comments on the United States Preventive Services Task Force (USPSTF) Draft Research Plan on Screening for Colorectal Cancer (“Draft Research Plan”). As the leading trade association representing medical imaging, radiotherapy, and radiopharmaceutical manufacturers, we have in-depth knowledge of the significant benefits Read More